AKT1 and breast carcinoma: Drawing from the observation that BCN1369 also exhibited elevated PI3K-Akt-mTOR signaling (Fig. 5b), together with a recent report that showed mTOR mediated MUC1 induction in multiple breast cancer cell lines30, these PDX models were additionally treated with the small molecule mTOR inhibitor everolimus.